Bette Liu

1 month ago | medrxiv.org | Alexandra B Hogan |David J Muscatello |Bette Liu |Gemma L. Nedjati-Gilani

ABH has previously received funding from the World Health Organization (both paid to the institution and individually) for work relating to modelling pandemic-era COVID-19 vaccine impact. BL declares grants paid to their institution from the Australian National Health and Medical Research Council and Medical Research Future Fund. ABH and DJM are supported by a National Health and Medical Research Council (NHMRC) Investigator Grants (APP2009278, APP1194109).

Aug 13, 2024 | medrxiv.org | Bette Liu |Sandrine Stepien |Kristine Macartney |Anish Scaria

BL's institution receives grant funding from the Australian National Health and Medical Research Council and the Medical Research Future Fund and Wellcome Trust. From 2019-2023 BL was a member of the Australian Technical Advisory Group on Immunisation. KM's institution has received funding from Australian and State Government Departments of Health, Australian National Health and Medical Research Council, GAVI, WHO and Wellcome Trust. KM has served as an expert witness for State Governments.

Nov 10, 2023 | medicalxpress.com | James H Wood |Bette Liu |Katie Flanagan |Stuart Turville

Australia is now into its next COVID wave. We've seen hints of this for a while. Case numbers and indicators of severe disease began rising in Victoria in August. But it has taken several months for a consistent pattern to emerge across Australia. Now we see evidence of this new wave via wastewater surveillance for traces of SARS-CoV-2, the virus that causes COVID. We also see rises in COVID-related hospital admissions and antiviral prescriptions.

Nov 9, 2023 | theconversation.com | James Wood |Bette Liu |Katie Flanagan |Stuart Turville

Australia is now into its next COVID wave. We’ve seen hints of this for a while. Case numbers and indicators of severe disease began rising in Victoria in August. But it has taken several months for a consistent pattern to emerge across Australia. Now we see evidence of this new wave via wastewater surveillance for traces of SARS-CoV-2, the virus that causes COVID. We also see rises in COVID-related hospital admissions and antiviral prescriptions.

Oct 7, 2023 | thelancet.com | Bette Liu |UNSW Sydney |Sandrine Stepien |Timothy Dobbins

Research in contextMany studies have estimated COVID-19 vaccine effectiveness against COVID-19 specific disease outcomes including symptomatic infection and severe disease, often measured using hospitalisations and deaths with a related SARS-CoV-2 diagnosis. Defining severe COVID-19 has become more difficult in the Omicron variant era as infection is common and misclassification of attribution can lead to uncertainty and variations in vaccine effectiveness estimates.